Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BCHE as a Prognostic Biomarker in Endometrial Cancer and Its Correlation with Immunity

21 Jul 2022

Abstract excerpt

Background: In developed countries, the most common gynecologic malignancy is endometrial carcinoma (EC), making the identification of EC biomarkers extremely essential. As a natural enzyme, butyrylcholinesterase (BCHE) is found in hepatocytes and plasma. There is a strong correlation between BCHE gene mutations and cancers and other diseases. The aim of this study was to analyze the role of BCHE in patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 14-3-3 protein interactions
Share to Cancer, Stress, Anesthesia, and Immune Response
Share to Cholinesterase and Neurodegenerative Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35915658
DOI: 10.1155/2022/6051092

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BCHE as a Prognostic Biomarker in Endometrial Cancer and Its Correlation with ImmunityPMID 35915658Read ↗

Identification of molecular markers associated with the progression and prognosis of endometrial cancer: a bioinformatic studySemantic proximity Read ↗

ZBTB7A, a potential biomarker for prognosis and immune infiltrates, inhibits progression of endometrial cancer based on bioinformatics analysis and experimentsSemantic proximity Read ↗

Exploration of a novel prognostic risk signatures and immune checkpoint molecules in endometrial carcinoma microenvironment.Semantic proximity Read ↗

UBE2T is a diagnostic and prognostic biomarker for endometrial cancerSemantic proximity Read ↗

Development and validation of two redox-related genes associated with prognosis and immune microenvironment in endometrial carcinomaSemantic proximity Read ↗

Diagnosis and Prediction of Endometrial Carcinoma Using Machine Learning and Artificial Neural Networks Based on Public DatabasesSemantic proximity Read ↗

Lipid-Metabolism-Related Gene Signature Predicts Prognosis and Immune Microenvironment Alterations in Endometrial CancerSemantic proximity Read ↗

Discovery of biomarkers for endometrial cancer: current status and prospectsSemantic proximity Read ↗

Identification of key genes associated with endometriosis and endometrial cancer by bioinformatics analysisSemantic proximity Read ↗

Development of Biomarker Signatures Associated with Anoikis to Predict Prognosis in Endometrial Carcinoma PatientsSemantic proximity Read ↗

Genetic variation perspective reveals potential drug targets for subtypes of endometrial cancer.Semantic proximity Read ↗

LPCAT1 is a Prognostic Biomarker and Correlated with Tumor Microenvironment in Endometrial CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.